Evidence map›Paper›PMID 24504096›Full record

ArticleChest2014

Antiinflammatory therapy outcomes for mild OSA in children.

Leila Kheirandish-Gozal, Rakesh Bhattacharjee, Hari P R Bandla, David Gozal

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Chest, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05911646 (OSA-18 in Children With Mild Obstructive Sleep Apnea), which is not on this map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05911646 narecruitingnot on this mapstarted 2021, after this paper: background citation

OSA-18 in Children With Mild Obstructive Sleep Apnea: Can it be a Helpful Decision Making Tool?

TypeinterventionalSponsorConnecticut Children's Medical CenterRan2021 to 2027Enrolled130ConditionsApnea, Obstructive Sleep, Obstructive Sleep ApneaArmsOSA-18 Survey, Decisional Conflict (DCS)
3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 137 citations in OpenAlex.

  1. Guideline
  2. Nasal biomarker inflammatory profile in response to intranasal corticosteroids in pediatric obstructive sleep apnea syndrome.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2025
    Trial
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Dynamic genetic regulation of CD4Frontiers in immunology · 2025
    Article
  11. Review
  12. Article
  13. Review
  14. Allergic rhinitis facts from an Irish pediatric population.World journal of otorhinolaryngology - head and neck surgery · 2023
    Article
  15. Review
  16. International Consensus Statement on Obstructive Sleep Apnea.International forum of allergy & rhinology · 2023
    Review
  17. Review
  18. Innovations in the Treatment of Pediatric Obstructive Sleep Apnea.Advances in experimental medicine and biology · 2022
    Article
  19. Article
  20. Alternatives to surgery in children with mild OSA.World journal of otorhinolaryngology - head and neck surgery · 2021
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Leila Kheirandish-GozalSection of Pediatric Sleep Medicine, Department of Pediatrics, Biological Sciences Division, Pritzker School of Medicine, The University of Chicago, Chicago, IL.
Rakesh BhattacharjeeSection of Pediatric Sleep Medicine, Department of Pediatrics, Biological Sciences Division, Pritzker School of Medicine, The University of Chicago, Chicago, IL.
Hari P R BandlaSection of Pediatric Sleep Medicine, Department of Pediatrics, Biological Sciences Division, Pritzker School of Medicine, The University of Chicago, Chicago, IL.
David GozalSection of Pediatric Sleep Medicine, Department of Pediatrics, Biological Sciences Division, Pritzker School of Medicine, The University of Chicago, Chicago, IL. Electronic address: dgozal@peds.bsd.uchicago.edu.
University of Chicago · US

Funding

NEUROCOGNITIVE FUNCTION IN SNORING CHILDRENR01HL065270 · NHLBI · UNIVERSITY OF LOUISVILLE · PI GOZAL, DAVID · 1999 to 2014
$5.0M
Oxidative stress in a murine model of sleep apneaR01HL086662 · NHLBI · UNIVERSITY OF LOUISVILLE · PI GOZAL, DAVID · 2008 to 2012
$1.9M
Validation of Urinary Biomarkers in Diagnosis of Pediatric OSAP50HL107160 · NHLBI · UNIVERSITY OF CHICAGO · PI GOZAL, DAVID · 2011 to 2012
$923k
NHLBI NIH HHS P50 HL107160NHLBI NIH HHS R01 HL065270NHLBI NIH HHS R01 HL086662
6 · The paper itself

Abstract

backgroundOSA is highly prevalent in children and usually initially treated by adenotonsillectomy. Nonsurgical alternatives for mild OSA primarily consisting of antiinflammatory approaches have emerged, but their efficacy has not been extensively assessed.

methodsA retrospective review of clinically and polysomnographically diagnosed patients with OSA treated between 2007 and 2012 was performed to identify otherwise healthy children ages 2 to 14 years who fulfilled the criteria for mild OSA and who were treated with a combination of intranasal corticosteroid and oral montelukast (OM) for 12 weeks (ICS + OM). A subset of children continued OM treatment for 6 to 12 months.

resultsA total of 3,071 children were diagnosed with OSA, of whom 836 fulfilled mild OSA criteria and 752 received ICS + OM. Overall, beneficial effects occurred in > 80% of the children, with nonadherence being documented in 61 children and adenotonsillectomy being ultimately performed in 12.3%. Follow-up polysomnography in a subset of 445 patients showed normalization of sleep findings in 62%, while 17.1% showed either no improvement or worsening of their OSA. Among the latter, older children (aged > 7 years; OR, 2.3; 95% CI, 1.43-4.13; P < .001) and obese children (BMI z-score > 1.65; OR: 6.3; 95% CI, 4.23-11.18; P < .000001) were significantly more likely to be nonresponders.

conclusionsA combination of ICS + OM as initial treatment of mild OSA appears to provide an effective alternative to adenotonsillectomy, particularly in younger and nonobese children. These results support implementation of multicenter randomized trials to more definitively establish the role of ICS + OM treatment in pediatric OSA.

Indexed as

AdolescentAnti-Inflammatory AgentsChildChild, PreschoolFemaleFollow-Up StudiesHumansMalePolysomnographyQuality of LifeRetrospective StudiesSeverity of Illness IndexSleep Apnea, ObstructiveTreatment OutcomeAnti-Inflammatory Agents

Identifiers

PMID24504096
PMCPMC4077412
OpenAlexW2031192973

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.